Offloading—the mechanical relief of pressure from a plantar wound—is widely regarded as the single most important intervention for healing a neuropathic diabetic foot ulcer. Yet a persistent paradox shadows clinical practice: the offloading devices proven most effective are frequently the ones least used, and a major reason is human behavior rather than biology. Understanding why removable devices underperform, and how patient and clinician adherence shapes outcomes, is central to closing the gap between what the evidence recommends and what patients actually receive.
Why Offloading Matters
In a person with peripheral neuropathy, the protective sensation that normally signals tissue damage is lost. Repetitive pressure during walking concentrates at the forefoot and midfoot, breaking down skin and preventing wounds from closing. Removing that mechanical load allows the wound bed to granulate and re-epithelialize. Decades of randomized controlled trials have established that non-removable knee-high casting heals neuropathic plantar ulcers in an average of roughly six weeks, with a high level of evidence, making offloading the most urgent and theoretically the simplest part of diabetic foot care to implement.
The Adherence Problem With Removable Devices
The mechanical effectiveness of a device means little if it is not worn. This is where removable cast walkers (RCWs) reveal their central weakness. A secondary analysis of step activity in patients using total contact casts (TCCs) versus removable cast walkers found that the percentage of ulcers that healed was substantially lower in the removable group (65% versus 93%), and that when ulcers did heal, average healing time was longer with removable devices (138 days versus 77 days). Notably, patients in the removable group took more daily steps and walked at a higher cadence—precisely the activity that loads a healing wound. Because removable devices can be taken off, they invite greater ambulation and inconsistent use, undermining the very protection they are meant to provide (Wendland et al., Advances in Skin & Wound Care, 2023).
This observation is reinforced at the level of pooled evidence. A rapid review with meta-analysis and trial sequential analysis of randomized trials found that non-removable fiberglass total contact casting produced shorter ulcer healing times than removable cast walkers, with the difference supported by trial sequential analysis (Okoli et al., BMJ Open Diabetes Research & Care, 2022). A health technology assessment of thirteen randomized trials similarly concluded that healing rates were higher with total contact casts and irremovable cast walkers than with removable walkers, and that the non-removable options were also less expensive over time because they reduced costly complications such as amputation (Ontario Health Technology Assessment Series, 2017).
The Clinician Side of the Gap
Adherence is not solely a patient issue. Even when the evidence is clear, the gold-standard devices are frequently not offered. A survey of prosthetic and orthotic clinics in Sweden found that practitioners overwhelmingly provided modified off-the-shelf footwear with insoles—an intervention that guidelines specifically advise against as a primary treatment—while total contact casts were provided by only 20% of practitioners and non-removable knee-high walkers by none. Many respondents were unsure whether casting or a non-removable knee-high walker even represented the standard of care. The authors concluded that the pattern of practice was “almost exactly opposite” to evidence-based recommendations, attributing it in part to a lack of awareness of which devices are considered the gold standard (Gigante et al., Diabetes/Metabolism Research and Reviews, 2023).
Practical barriers compound this. Total contact casts have historically been viewed as time-consuming and technically demanding to apply, and they prevent direct inspection of the wound between visits—a real concern in patients with infection risk or peripheral arterial disease. Innovations aim to address these obstacles: streamlined TCC systems can be applied in roughly seven minutes with immediate ambulation (Liden, Surgical Technology International, 2017), and windowed cast designs have been described that preserve irremovable offloading while allowing access to inspect the foot, even in higher-risk patients (Hochlenert & Fischer, Journal of Diabetes Science and Technology, 2020).
Bridging the Divide
The evidence points to a consistent hierarchy: non-removable knee-high devices heal neuropathic plantar ulcers faster and more reliably than removable alternatives, largely because they guarantee consistent use and limit step activity. When a non-removable device is genuinely contraindicated—or a patient cannot tolerate it—a removable knee-high device is a reasonable second choice, but its success depends heavily on the patient actually wearing it as directed. Rendering a removable walker irremovable, through a simple wrap, captures much of the benefit of full casting while retaining ease of fitting.
Key Takeaways
Offloading is the cornerstone of neuropathic ulcer healing, but its real-world effectiveness is determined as much by adherence as by biomechanics. Removable devices underperform chiefly because they are removed, permitting harmful ambulation, while non-removable devices enforce the consistent pressure relief that wounds require. The gap between guideline recommendations and everyday practice persists on both sides of the encounter: patients who remove devices and clinicians who under-prescribe the most effective options. Narrowing that gap—through clinician education, faster and more tolerable casting techniques, and frank conversations about consistent use—offers one of the clearest opportunities to speed healing and prevent amputation in diabetic foot care.
References
Wendland DM, Kline PW, Bohnert KL, Biven TM, Sinacore DR. Offloading of Diabetic Neuropathic Plantar Ulcers: Secondary Analysis of Step Activity and Ulcer Healing. Advances in Skin & Wound Care. 2023;36(4):194–200.
Okoli GN, Rabbani R, Lam OLT, et al. Offloading devices for neuropathic foot ulcers in adult persons with type 1 or type 2 diabetes: a rapid review with meta-analysis and trial sequential analysis of randomized controlled trials. BMJ Open Diabetes Research & Care. 2022;10(3):e002822.
Health Quality Ontario. Fibreglass Total Contact Casting, Removable Cast Walkers, and Irremovable Cast Walkers to Treat Diabetic Neuropathic Foot Ulcers: A Health Technology Assessment. Ontario Health Technology Assessment Series. 2017;17(12):1–124.
Gigante I, Sigurjónsdóttir ED, Jarl G, Hellstrand Tang U. Offloading of diabetes-related neuropathic foot ulcers at Swedish prosthetic and orthotic clinics. Diabetes/Metabolism Research and Reviews. 2023;39(4):e3611.
Liden B. Total Contact Cast System to Heal Diabetic Foot Ulcers. Surgical Technology International. 2017;30:71–76.
Hochlenert D, Fischer C. Ventral Windowed Total Contact Casts Safely Offload Diabetic Feet and Allow Access to the Foot. Journal of Diabetes Science and Technology. 2020;16(1):137–143.
Ha Van G. Why and how to off-load a diabetic foot ulcer? La Revue du Praticien. 2019;69(6):616–619.
Comments
